Skip to main content

Find Clinical Trials

Home
Conditions
Early-stage BAP1-associated Malignancies

Clinical trial condition

Early-stage BAP1-associated Malignancies

Explore clinical trials studying Early-stage BAP1-associated Malignancies. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

Early-stage BAP1-associated Malignancies trial results

Recruiting

Decitabine/Cedazuridine (INQOVI), an Oral DNA Demethylating Agent, in Subjects With BAP1 Cancer Predisposition Syndrome and Subclinical, Early-Stage Mesothelioma

NCT05960773

Conditions: Adenoma, BRCA1-Associated Protein-1 (BAP1) Mutations, Early-stage BAP1-associated Malignancies, +16 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details